American Society of Hirudotherapy

Long-term survey of sea turtles (Caretta caretta) reveals correlations between parasite infection, feeding ecology, reproductive success and population dynamics

Population study published in Scientific Reports (2020)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Safety & Infection ControlLockley EC et al. · Scientific reports, 2020

Abstract

Long-term monitoring of host-parasite interactions is important for understanding the consequences of infection on host fitness and population dynamics. In an eight-year survey of the loggerhead sea turtle (Caretta caretta) population nesting in Cabo Verde, we determined the spatiotemporal variation of Ozobranchus margoi, a sanguivorous leech best known as a vector for sea turtle fibropapilloma virus. We quantified O. margoi association with turtles' δ15N and δ13C stable isotopes to identify where infection occurs. We then measured the influence of infection on reproduction and offspring fitness. We found that parasite prevalence has increased from 10% of the population in 2010, to 33% in 2017. Stable isotope analysis of host skin samples suggests transmission occurs within the host's feeding grounds. Interestingly, we found a significant interaction between individual size and infection on the reproductive success of turtles. Specifically, small, infected females produced fewer offspring of poorer condition, while in contrast, large, infected turtles produced greater clutch sizes and larger offspring. We interpret this interaction as evidence, upon infection, for a size-dependent shift in reproductive strategy from bet hedging to terminal investment, altering population dynamics. This link between infection and reproduction underscores the importance of using long-term monitoring to quantify the impact of disease dynamics over time.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsEcologyFemaleHost-Parasite InteractionsLeechesParasitic Diseases, AnimalPopulation DynamicsReproductionTurtles

Summary

An eight-year loggerhead turtle survey in Cabo Verde tracked rising Ozobranchus margoi leech prevalence (10% to 33%) and stable-isotope-localized transmission to feeding grounds; infection interacted with body size to shift reproductive strategy.

Context

This eight-year field survey studied the spatiotemporal dynamics of Ozobranchus margoi—a sanguivorous leech parasitic on loggerhead sea turtles and a vector for fibropapilloma virus—in the Cabo Verde nesting population, examining correlations between infection prevalence, stable isotope-derived feeding ecology, reproductive success, and population dynamics. The study found parasite prevalence increased from 10% to 33% over the survey period and identified a size-dependent interaction between infection and reproductive strategy in turtles. This article concerns wild parasite ecology in a non-medicinal leech species affecting sea turtle populations.

Citation

Reference (Vancouver style)

Lockley EC, Fouda L, Correia SM, Taxonera A, Nash LN, Fairweather K, et al. Long-term survey of sea turtles (Caretta caretta) reveals correlations between parasite infection, feeding ecology, reproductive success and population dynamics. Sci Rep. 2020;10(1):18569. doi:10.1038/s41598-020-75498-4. PMID: 33122760

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.